You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 10, October 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (35)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Glaucoma
 •Ophthalmological Disorders, Other
 •Alert me on articles by topic

The Relationship Between Glaucoma and Pseudoexfoliation

The Blue Mountains Eye Study

Paul Mitchell, MD, FRACO, FRCOphth; Jie Jin Wang, MBBS, MMed(Clin Epi); Fleur Hourihan, BSc, MPH

Arch Ophthalmol. 1999;117:1319-1324.

Objective  To quantify the relationship between pseudoexfoliation (PXF) and open-angle glaucoma, ocular hypertension, and intraocular pressure (IOP) in a defined older population.

Methods  A cross-sectional study of 3654 people aged 49 to 97 years identified subjects with PXF during slitlamp examination. The IOP was measured by applanation tonometry. Glaucoma was diagnosed from characteristic visual field loss combined with optic disc cupping and rim thinning, without reference to IOP. Ocular hypertension was diagnosed if IOP was greater than 21 mm Hg in either eye, without field and disc changes. General estimating equation models were used to assess associations between eyes with PXF and glaucoma or ocular hypertension.

Results  Pseudoexfoliation was diagnosed in 2.3% of subjects, and both prevalence and bilaterality increased with age. Glaucomatous damage was present in 14.2% of eyes with PXF compared with 1.7% of eyes without PXF (age- and sex-adjusted odds ratio (OR), 5.0; 95% confidence interval (CI), 2.6-9.6). This was almost unchanged (OR, 4.8) after adjustment for glaucoma risk factors and was also relatively unaffected by IOP adjustment (OR, 3.7; 95% CI, 1.8-7.6). For subjects with PXF, the relationship with glaucoma persisted, but was weaker (OR, 2.3; 95% CI, 1.0-5.0) in the multivariate model. However, the population attributable risk from PXF was only 2.7%. Ocular hypertension was also more frequent in eyes with PXF (9.3%) than in eyes without PXF (3.1%) but was of borderline significance in the multivariate model (OR, 2.3; 95% CI, 0.9-5.7).

Conclusions  This study confirmed the strong relationship between glaucoma and PXF. Subjects with PXF had an increased risk of glaucoma, while eyes with PXF had a higher risk, which was independent of other glaucoma risk factors, including IOP.


From the Department of Ophthalmology, Westmead Hospital, University of Sydney, Sydney, Australia.


RELATED ARTICLE

Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 1999;117(10):1452.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people
Hewitt et al.
Hum Mol Genet 2008;17:710-716.
ABSTRACT | FULL TEXT  

Genome-Wide Scan of Exfoliation Syndrome
Lemmela et al.
IOVS 2007;48:4136-4142.
ABSTRACT | FULL TEXT  

Pseudoexfoliation in Southern India: The Andhra Pradesh Eye Disease Study
Thomas et al.
IOVS 2005;46:1170-1176.
ABSTRACT | FULL TEXT  

The prevalence of pseudoexfoliation syndrome in Chinese people: the Tanjong Pagar Survey
Foster and Seah
Br. J. Ophthalmol. 2005;89:239-240.
FULL TEXT  

Risk Factors Associated with the Incidence of Open-Angle Glaucoma: The Visual Impairment Project
Le et al.
IOVS 2003;44:3783-3789.
ABSTRACT | FULL TEXT  

Exfoliation Syndrome in Black South Africans
Rotchford et al.
Arch Ophthalmol 2003;121:863-870.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.